- Section 1 Hallmarks of cancer
- Section 2 Aetiology and epidemiology of cancer
- Section 3 Principles of oncology
- Section 4 Population health
- Section 5 Support for the cancer patient
- Section 6 Disease orientated chapters
- Chapter 35 Head and neck cancer
- Chapter 36 Oesophageal cancer
- Chapter 37 Gastric cancer
- Chapter 38 Rectal cancer and systemic therapy of colorectal cancer
- Chapter 39 Colorectal cancer
- Chapter 40 Pancreatic cancer
- Chapter 41 Hepatobiliary cancers
- Chapter 42 Peritoneal mesothelioma
- Chapter 43 Cancer of the breast
- Chapter 44 Gynaecological cancers
- Chapter 45 Genitourinary cancers
- Chapter 46 Lung cancer
- Chapter 47 Neoplasms of the thymus
- Chapter 48 Pleural mesothelioma
- Chapter 49 Skin cancer: melanoma
- Chapter 50 Skin cancer: non-melanoma
- Chapter 51 Acute leukaemias
- Chapter 52 Chronic leukaemias
- Chapter 53 Myeloma
- Chapter 54 Malignant lymphomas
- Chapter 55 Sarcomas of soft tissues and bone and gastrointestinal stromal tumour
- Chapter 56 Craniospinal malignancies
- Chapter 57 Tumours of the eye and orbit
- Chapter 58 Endocrine cancers
- Chapter 59 Cancer of unknown primary site
(p. 690) Skin cancer: non-melanoma
- (p. 690) Skin cancer: non-melanoma
Diona L. Damian
, Richard A. Scolyer
, Graham Stevens
, Alexander Guminski
, and John F. Thompson
Further rise in incidence and economic cost of NMSC in Western countries.
Updated classification of BCC into high and low risk.
Hedgehog Pathway Inhibitors have established a role as systemic treatment for inoperable or metastatic BCC.
Anti-PD1 immunotherapy has demonstrated efficacy in inoperable and metastatic SCC.
Merkel Cell carcinomas appear to have either a viral or UV damage aetiology.
Checkpoint Inhibitors (Anti-PD1 or anti-PD-L1) are preferred treatment for metastatic Merkel Cell Carcinomas.
Oral Nicotinamide significantly reduces the incidence of NMSC in high risk, heavily sun-damaged individuals.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.